Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 YearsAndrea Calcagno, Paola Pignata, Agostino Riva et al.|Open Forum Infectious Diseases|2025Cited by 0